Live Breaking News & Updates on Obstructive hypertrophic cardiomyopathy

Stay informed with the latest breaking news from Obstructive hypertrophic cardiomyopathy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Obstructive hypertrophic cardiomyopathy and stay connected to the pulse of your community

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Lisbon , Lisboa , Portugal , Scotland , Martin-maron , Cytokinetics-diane-weisersenior , Mary-ellen-jay , Gregory-lewis , Scotland-inherited-cardiac-conditions-service , Cytokinetics-incorporated , Linkedin

REMS Program Resources for Clinicians

An expert cardiologist discusses the importance of healthcare provider education and finding resources around the REMS program.

United-states , Massachusetts , Jamesl-januzzi , Hospital-heart-center , Drug-administration , Risk-evaluation , Mitigation-strategy , United-states-food , Massachusetts-general-hospital-heart-center , Rems , Resources

Using Cardiac Myosin Inhibitors for the Treatment of oHCM

Dr James L. Januzzi reviews the use of cardiac myosin inhibitors for the management of oHCM.

Jamesl-januzzi , Cardiac-myosin-inhibitors , Treatment-of-ohcm , Obstructive-hypertrophic-cardiomyopathy , Mavacamten , Aficamten ,

Clinical Trial Outcomes for Cardiac Myosin Inhibitors in oHCM Treatment

An expert in cardiology shares clinical trial findings of emerging and approved cardiac myosin inhibitors for the treatment of oHCM.

Jamesl-januzzi , Clinical-trial-outcomes , Cardiac-myosin-inhibitors , Ohcm-treatment , Obstructive-hypertrophic-cardiomyopathy , Peak-v02 , Safety , Ejection-fraction , Good-monitoring , Explorer-hcm , Valor-hcm

Cytokinetics Reports Fourth Quarter 2023 Financial Results

Cytokinetics Reports Fourth Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Ji-xing , Roberti-blum , Cytokinetics-diane-weisersenior , Office-of-new-drugs , Ongoing-research , Research-evaluation-of-sustained-treatment , International-symposium , Exchange-commission , Us-food-drug-administration , Facebook , Cytokinetics-incorporated-nasdaq

Role of Small-Molecule Myosin Inhibitors in oHCM Treatment

James L. Januzzi, MD, provides insight on the pathophysiology of obstructive hypertrophic cardiomyopathy (oHCM) and comments on small-molecule myosin inhibitors as an emerging therapeutic option.

Jamesl-januzzi , Small-molecule-myosin-inhibitors , Ohcm , Treatment , Obstructive-hypertrophic-cardiomyopathy , Sarcomere , Mutations , Myocardial-hypercontractility , Lvot-obstruction ,

Unmet Needs in oHCM Care

An expert cardiologist examines unmet needs and bridging the gap in care for patients with oHCM.

Jamesl-januzzi , Unmet-needs , Ohcm-care , Obstructive-hypertrophic-cardiomyopathy , Risk-for-major-adverse-cardiovascular-events , Health-status , Qol , Invasive-treatments , Septal-reduction-therapy , Physiology , Reducing-lvot-gradient

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Cambridge , Cambridgeshire , Cytokinetics-diane-weisersenior , Ahmad-masri , Exchange-commission , Facebook , Linkedin , Cytokinetics-incorporated , Corporate-communications

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
nrtoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nrtoday.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Cambridge , Cambridgeshire , Oregon , United-states , Diane-weiser , Ahmad-masri , Corporate-communications , Cytokinetics-incorporated-nasdaq , Exchange-commission

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , London , City-of , Cytokinetics-incorporated , Obstructive-hypertrophic-cardiomyopathy ,

Live Breaking News & Updates on Obstructive hypertrophic cardiomyopathy

Dr James L. Januzzi reviews the use of cardiac myosin inhibitors for the management of oHCM.Jamesl-januzzi , Cardiac-myosin-inhibitors , Treatment-of-ohcm , Obstructive-hypertrophic-cardiomyopathy , Mavacamten , Aficamten ,

Dr James L. Januzzi reviews the use of cardiac myosin inhibitors for the management of oHCM.

Jamesl-januzzi , Cardiac-myosin-inhibitors , Treatment-of-ohcm , Obstructive-hypertrophic-cardiomyopathy , Mavacamten , Aficamten ,